SEC Filing • AbbVie Inc.
AbbVie Inc. (ABBV) files 10-Q for Q3 2025
👤 SEC
📅 Nov 4, 2025 7:05 PM (5 months ago)
🐻 Somewhat negative (70%)
AI Sentiment Analysis
Based on preliminary searches, analyst expectations for AbbVie's Q3 2025 revenue were approximately $16 billion and EPS around $3. Revenue came in lower at $15.776 billion, and EPS significantly missed expectations at $0.1. Therefore, AbbVie missed on both revenue and EPS, leading to a 'Somewhat negative' sentiment.